Showing results (191-200 of 391) with videos related to
Sort By:
Pageof 40
Clinical and Experimental Vaccine Research|October 27, 2021
Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center studyYu Min Kang, Jaegyun Lim, Kang-Won Choe, et al.Clinical and Experimental Vaccine Research|February 28, 2022
Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattleSerdar Uzar, Fahriye Sarac, Veli Gulyaz, et al.Clinical and Experimental Vaccine Research|February 28, 2022
Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccinesShaimaa Abulmagd, Abd El-Nasser A Khattab, Hamdallah ZedanClinical and Experimental Vaccine Research|February 28, 2022
COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine productionEmmanuel Lamptey, Ephraim Kumi Senkyire, Dooshima Aki Benita, et al.Clinical and Experimental Vaccine Research|February 28, 2022
Factors associated with side effects of COVID-19 vaccine in IndonesiaJohan Wibowo, Rivaldo Steven Heriyanto, Felix Wijovi, et al.Clinical and Experimental Vaccine Research|February 8, 2017
Enterovirus 71 infection and vaccinesEun-Je Yi, Yun-Ju Shin, Jeong-Hwan Kim, et al.Clinical and Experimental Vaccine Research|February 8, 2017
The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvantsSae-Hae Kim, Yong-Suk JangClinical and Experimental Vaccine Research|February 8, 2017
Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtrationYoung Chan Park, Jae Min SongClinical and Experimental Vaccine Research|February 25, 2021
Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccineMajdedin Ghalavand, Mojtaba Saadati, Jafar Salimian, et al.Clinical and Experimental Vaccine Research|February 25, 2021
Pan-vasculitis and fulminant hepatitis following routine vaccination at the age of 4 monthsMohammad Hosny Awad, Amany El-Hawary, Gehan Sawah, et al.Pageof 40